Literature DB >> 1569175

Epidermal growth factor and its receptor in human implantation trophoblast: immunohistochemical evidence for autocrine/paracrine function.

G E Hofmann1, M R Drews, R T Scott, D Navot, D Heller, L Deligdisch.   

Abstract

Epidermal growth factor (EGF) and its receptor (EGF-R) were immunohistochemically localized in trophoblast during human implantation from intrauterine and ectopic pregnancies. EGF immunostaining was absent to light in the cytotrophoblast (CT), light to moderate in intermediate trophoblast (IT), and intense in the syncytiotrophoblast (ST). In ST, EGF immunostaining was found mostly in the cytoplasm; however, staining of the plasma membrane was also noted. Immunostaining for the EGF-R was absent to light in the CT and moderate to intense in the IT. Immunostaining for the EGF-R was intense in the ST, with moderate staining in the cytoplasm and intense staining in the plasma membrane. Staining was most intense on the microvilli of the ST. Additionally, EGF-R immunostaining could be demonstrated on nuclear membranes. The increase in the intensity of the immunostaining for both EGF and EGF-R noted in CT, IT, and ST suggests a differentiated expression of this receptor-ligand system in human trophoblast and provides evidence for an autocrine/paracrine role for EGF in trophoblast function. The presence of this receptor-ligand system during early human implantation strongly supports a role for EGF and the EGF-R in embryo-uterine signalling and the implantation process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569175     DOI: 10.1210/jcem.74.5.1569175

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Diverse functions of HBEGF during pregnancy.

Authors:  Philip Jessmon; Richard E Leach; D Randall Armant
Journal:  Mol Reprod Dev       Date:  2009-12       Impact factor: 2.609

2.  Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos.

Authors:  J Dackor; K E Strunk; M M Wehmeyer; D W Threadgill
Journal:  Placenta       Date:  2007-09-05       Impact factor: 3.481

3.  Epidermal growth factor abrogates hypoxia-induced apoptosis in cultured human trophoblasts through phosphorylation of BAD Serine 112.

Authors:  Rachel G Humphrey; Christina Sonnenberg-Hirche; Steven D Smith; Chaobin Hu; Aaron Barton; Yoel Sadovsky; D Michael Nelson
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

4.  Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors.

Authors:  Lukas Hechelhammer; Stephan Störkel; Bernhard Odermatt; Philipp U Heitz; Wolfram Jochum
Journal:  Virchows Arch       Date:  2003-06-03       Impact factor: 4.064

5.  Preimplantation embryo development enhanced by epidermal growth factor.

Authors:  R P Buyalos; X Cai
Journal:  J Assist Reprod Genet       Date:  1994-01       Impact factor: 3.412

6.  Alterations of human placental epidermal growth factor receptor in intrauterine growth retardation.

Authors:  C Fondacci; E Alsat; R Gabriel; P Blot; C Nessmann; D Evain-Brion
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

7.  Exposure to Phthalate, an Endocrine Disrupting Chemical, Alters the First Trimester Placental Methylome and Transcriptome in Women.

Authors:  N M Grindler; L Vanderlinden; R Karthikraj; K Kannan; S Teal; A J Polotsky; T L Powell; I V Yang; T Jansson
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.